Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000019

CEO bought 54,500 shares at an average $0.02 ($1,099)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-13 Purchase : show line 1 in the form +2,000 $0.02 $37 21,816,123 D
2019-03-13 Purchase : show line 2 in the form +500 $0.02 $10 21,816,623 D
2019-03-14 Purchase : show line 3 in the form +2,000 $0.02 $38 21,818,623 D
2019-03-14 Purchase : show line 4 in the form +5,000 $0.02 $108 21,823,623 D
2019-03-15 Purchase : show line 5 in the form +5,000 $0.02 $104 21,828,623 D
2019-03-15 Purchase : show line 6 in the form +5,000 $0.02 $105 21,833,623 D
2019-03-15 Purchase : show line 7 in the form +5,000 $0.02 $100 21,838,623 D
2019-03-15 Purchase : show line 8 in the form +5,000 $0.02 $100 21,843,623 D
Open-market purchases · 54,500 sh · avg $0.02 · $1,099
Loading xslF345X03/primary_doc.xml…